| |
| |
|
| Insider
Information: |
Parschauer Karah Herdman |
| Relationship: |
Director |
| City: |
Novato |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
105,047 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,391,684 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
105,047 |
|
|
| Total
Value |
$3,391,684 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
12
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
10
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -108.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ultragenyx Pharmaceutical Inc |
RARE |
|
2024-03-01 |
67,340 |
2016-06-20 |
0 |
Premium* |
|
|
Evolus Inc |
EOLS |
Director |
2024-02-07 |
37,707 |
2021-02-05 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RARE |
Ultragenyx Pharmaceutical... |
EVP and Chief Legal Officer |
• – – |
2024-03-01 |
4 |
S |
$53.76 |
$201,923 |
D/D |
(3,756) |
67,340 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
EVP and Chief Legal Officer |
• – – |
2024-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
18,757 |
70,739 |
0 |
- |
|
| EOLS |
Evolus Inc |
Director |
– • – |
2024-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
6,464 |
37,707 |
0 |
- |
|
| EOLS |
Evolus Inc |
Director |
– • – |
2024-01-30 |
4 |
S |
$13.14 |
$156,733 |
D/D |
(11,931) |
31,243 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
EVP and Chief Legal Officer |
• – – |
2023-05-04 |
4 |
AS |
$45.00 |
$197,010 |
D/D |
(4,378) |
51,982 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
EVP and Chief Legal Officer |
• – – |
2023-03-01 |
4 |
S |
$45.25 |
$143,035 |
D/D |
(3,161) |
56,139 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
EVP and Chief Legal Officer |
• – – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
24,663 |
59,101 |
0 |
- |
|
| EOLS |
Evolus Inc |
Director |
– • – |
2023-01-27 |
4 |
A |
$0.00 |
$0 |
D/D |
8,293 |
43,174 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
EVP and Chief Legal Officer |
• – – |
2022-03-07 |
4 |
S |
$62.95 |
$323,563 |
D/D |
(5,140) |
34,438 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
EVP and Chief Legal Officer |
• – – |
2022-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
14,000 |
39,578 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
EVP and Chief Legal Officer |
• – – |
2022-03-01 |
4 |
S |
$66.62 |
$192,265 |
D/D |
(2,886) |
25,472 |
0 |
% |
|
| EOLS |
Evolus Inc |
Director |
– • – |
2022-01-24 |
4 |
A |
$0.00 |
$0 |
D/D |
15,568 |
34,881 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
EVP and General Counsel |
• – – |
2021-10-14 |
4 |
S |
$81.14 |
$25,153 |
D/D |
(310) |
28,358 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
EVP and General Counsel |
• – – |
2021-09-08 |
4 |
S |
$100.65 |
$738,368 |
D/D |
(7,336) |
28,668 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
EVP and General Counsel |
• – – |
2021-09-08 |
4 |
OE |
$54.50 |
$399,812 |
D/D |
7,336 |
36,004 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
EVP and General Counsel |
• – – |
2021-06-10 |
4 |
AS |
$100.00 |
$132,900 |
D/D |
(1,329) |
28,668 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
EVP and General Counsel |
• – – |
2021-05-06 |
4 |
S |
$113.67 |
$35,579 |
D/D |
(313) |
29,997 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
EVP and General Counsel |
• – – |
2021-03-01 |
4 |
S |
$138.17 |
$548,535 |
D/D |
(3,970) |
30,227 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
EVP and General Counsel |
• – – |
2021-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,136 |
34,197 |
0 |
- |
|
| EOLS |
Evolus Inc |
Director |
– • – |
2021-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
19,313 |
19,313 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
EVP and General Counsel |
• – – |
2020-10-30 |
4 |
AS |
$100.12 |
$991,488 |
D/D |
(9,903) |
24,061 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
EVP and General Counsel |
• – – |
2020-10-30 |
4 |
OE |
$54.50 |
$539,714 |
D/D |
9,903 |
33,871 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
EVP and General Counsel |
• – – |
2020-10-28 |
4 |
AS |
$100.00 |
$9,700 |
D/D |
(97) |
23,968 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
EVP and General Counsel |
• – – |
2020-10-28 |
4 |
OE |
$54.50 |
$5,287 |
D/D |
97 |
24,065 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
EVP and General Counsel |
• – – |
2020-10-14 |
4 |
S |
$88.00 |
$28,600 |
D/D |
(325) |
23,968 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
